Publication Date | SPC No. | SPC Category | Details Rows may repeat to show multiple inventors or applicants depending on "Sort By" |
---|
17 August 2022
(Journal 6952)
| SPC/GB08/003 | Expired | Applicant: F.Hoffmann-La Roche AG 4070 Basel, Switzerland
Product: Methoxy Polyethylene Glycol-Epoetin Beta
Product Type: Medicinal Authorised: UK EU/1/07/400/001-016 24 July 2007
Authorised Extension:
Patent No: EP1064951 Title: Erythropoietin Derivative
SPC No: SPC/GB08/003 Date Expired: 23 July 2022 |
17 August 2022
(Journal 6952)
| SPC/GB10/006 | Expired | Applicant: Bayer Intellectual Property GmbH Alfred-Nobel-Strasse 10, 40789 Monheim an Rhein, Germany
Product: Spirotetramat
Product Type: Plant Protection Authorised: AT 191.041/41-BAES/08 8 September 2008 UK 1903 of 2009 13 August 2009
Authorised Extension:
Patent No: EP0915846 Title: 2- and 2, 5-substituted phenylketoenols
SPC No: SPC/GB10/006 Date Expired: 22 July 2022 |
17 August 2022
(Journal 6952)
| SPC/GB13/065 | Extensions Lodged | Applicant: Japan Tobacco Inc 1-1, Toranomon 4-chome, Minato-ku, Tokyo 105 6927, Japan
Product: Elvitegravir
Product Type: Medicinal Authorised: UK EU/1/13/830/001 27 May 2013 UK EU/1/13/830/002 27 May 2013
Authorised Extension: EU/1/13/830 19 October 2017
Patent No: EP1564210 Title: 4-oxoquinoline compounds and utilisation thereof as HIV integrase inhibitors
SPC No: SPC/GB13/065 Date Lodged: 21 July 2022 |
17 August 2022
(Journal 6952)
| SPC/GB14/007 | Entered Into Force | Applicant: Zoetis Services LLC 10 Sylvan Way, Parsippany, New Jersey, 07054, United States of America
Product: Inactivated West Nile Virus, strain VM-2
Product Type: Medicinal Authorised: UK EU/2/08/086/001 25 November 2008 UK EU/2/08/086/002 25 November 2008 UK EU/2/08/086/003 25 November 2008
Authorised Extension:
Patent No: EP1427444 Title: West Nile Vaccine
SPC No: SPC/GB14/007 Date entered into force: 23 July 2022 Effective Period Expires On: 24 November 2023 |